Treasurer of the State of North Carolina
ALXN

Treasurer of the State of North Carolina’s Alexion Pharmaceuticals ALXN Stock Holding History

Treasurer of the State of North Carolina’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-76,950
Closed -$14.1M – 1041
2021
Q2 		$14.1M Sell
76,950
-1,110
-1% -$191K 0.08% 225
2021
Q1 		$11.9M Sell
78,060
-3,460
-4% -$535K 0.08% 247
2020
Q4 		$12.7M Buy
81,520
+270
+0.3% +$34.7K 0.08% 226
2020
Q3 		$9.3M Sell
81,250
-170
-0.2% -$18.3K 0.07% 261
2020
Q2 		$9.14M Sell
81,420
-22,951
-22% -$2.44M 0.08% 245
2020
Q1 		$9.37M Buy
104,371
+7,400
+8% +$726K 0.08% 212
2019
Q4 		$10.5M Buy
96,971
+1,180
+1% +$126K 0.09% 203
2019
Q3 		$9.38M Sell
95,791
-39,170
-29% -$4.42M 0.08% 204
2019
Q2 		$17.7M Buy
134,961
+1,270
+0.9% +$164K 0.11% 187
2019
Q1 		$18.1M Buy
133,691
+948
+0.7% +$118K 0.12% 175
2018
Q4 		$12.9M Sell
132,743
-482
-0.4% -$57K 0.09% 194
2018
Q3 		$18.5M Buy
133,225
+45,149
+51% +$5.66M 0.12% 178
2018
Q2 		$10.9M Buy
88,076
+54,830
+165% +$6.41M 0.11% 182
2018
Q1 		$3.71M Buy
+33,246
New +$3.97M 0.1% 223

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Treasurer of the State of North Carolina's ALXN Position: Q3 2021 in Review

Treasurer of the State of North Carolina sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 76,950 shares — an estimated $14.1M sold.

Treasurer of the State of North Carolina first reported a position in ALXN in Q1 2018 and held it in 14 quarters. The position peaked at $18.5M in Q3 2018. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Treasurer of the State of North Carolina reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 76,950 Alexion Pharmaceuticals shares in Q3 2021, an estimated $14.1M.
  • Treasurer of the State of North Carolina first reported a position in Alexion Pharmaceuticals in Q1 2018 and held it in 14 quarters.
  • Treasurer of the State of North Carolina's Alexion Pharmaceuticals position peaked at $18.5M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Treasurer of the State of North Carolina's 13F filing for Q3 2021, filed 3 Nov 2021.